Pat McAfee
Story Poster
58:43
Ask Liucci: Blue Bell Park's big weekend, mascot madness & more
7 mo ago by Billy Liucci
TexAgs' co-owner and executive editor has thoughts on a number of topics ranging from an important three-game series at Blue Bell Park to ranting about A&M's lack of a mascot. "The Source" tackled another round of subscriber questions on Aggie football, baseball and more.
Story Poster
15:24
Liucci reacts to A&M's home-opener getting ABC's primetime treatment
7 mo ago by Billy Liucci
College GameDay is heading to College Station for Texas A&M's Aug. 31 showdown with Notre Dame at Kyle Field as the Mike Elko era will begin in primetime. On Tuesday morning, TexAgs' co-owner and executive editor Billy Liucci joined TexAgs Radio to react to the news.
Story Poster
Texas A&M-Notre Dame selected for ABC's primetime slot on Aug. 31
7 mo ago by Richard Zane
On Tuesday morning, ABC and ESPN announced that Texas A&M's season-opener with Notre Dame has been selected for ABC's primetime slot at 6:30 p.m. CT on Aug. 31. Additionally, College GameDay will be in College Station that morning ahead of the clash at Kyle Field.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
13:03
McGee gives Mike Elko an 'A+' following February's National Signing Day
10 mo ago by David Nuño
Mike Elko & Co. put the finishing touches on the 2024 signing class on Wednesday as a hectic period of roster management is now in the rearview. On Thursday, former A&M QB Stephen McGee spoke to TexAgs about why he's so impressed with what Elko & Co. have accomplished.
Story Poster
14:40
For The Brand: Pat McAfee analyzes Texas A&M punter Braden Mann
6 yr ago by Gabe Bock
During Monday's edition of TexAgs Radio former NFL punter and current podcast host Pat McAfee joined to share his thoughts on the All-American caliber season from Aggie punter Braden Mann and A&M legend Shane Lechler.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.